Human interleukin-5 expressed in Escherichia coli has N-terminal modifications

Biochem J. 1992 Sep 15;286 ( Pt 3)(Pt 3):825-8. doi: 10.1042/bj2860825.

Abstract

Recombinant human interleukin-5 exists as four major isoforms all possessing N-terminal methionine. Peptide mapping and subsequent analysis by fast-atom-bombardment mass spectrometry (f.a.b.-m.s.) have shown that N-terminal modifications are the cause of the charge heterogeneity. In order of decreasing abundance, these are unmodified methionine, retention of N-terminal formyl group, oxidation of N-terminal methionine to sulphoxide and carbamoylation of the N-terminus. These results were confirmed by analysis of the reduced and alkylated intact protein by electrospray-ionization mass spectrometry. The implications of these findings for the production and characterization of recombinant proteins are briefly discussed.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Chromatography, High Pressure Liquid
  • Cloning, Molecular
  • Electrophoresis, Polyacrylamide Gel
  • Escherichia coli
  • Humans
  • Interleukin-5 / chemistry*
  • Interleukin-5 / genetics
  • Isoelectric Focusing
  • Peptide Mapping
  • Recombinant Proteins / chemistry
  • Recombinant Proteins / genetics
  • Spectrometry, Mass, Fast Atom Bombardment
  • Trypsin

Substances

  • Interleukin-5
  • Recombinant Proteins
  • Trypsin